Compare COSM & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COSM | PRPO |
|---|---|---|
| Founded | 2009 | N/A |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.8M | 38.3M |
| IPO Year | 2009 | 2000 |
| Metric | COSM | PRPO |
|---|---|---|
| Price | $0.22 | $23.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | ★ $2.95 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 28.5K |
| Earning Date | 11-24-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 46.15 | ★ 92.15 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $65,271,815.00 | $24,049,000.00 |
| Revenue This Year | $30.85 | $233.72 |
| Revenue Next Year | $51.74 | $22.61 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 19.93 | ★ 29.77 |
| 52 Week Low | $0.16 | $17.79 |
| 52 Week High | $0.77 | $33.63 |
| Indicator | COSM | PRPO |
|---|---|---|
| Relative Strength Index (RSI) | 37.39 | 63.48 |
| Support Level | $0.17 | $24.09 |
| Resistance Level | $0.28 | $24.78 |
| Average True Range (ATR) | 0.04 | 1.42 |
| MACD | -0.01 | 0.72 |
| Stochastic Oscillator | 19.71 | 98.77 |
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.